KR20050016706A - 사이클레소나이드 함유 멸균 수성 현탁액 - Google Patents
사이클레소나이드 함유 멸균 수성 현탁액Info
- Publication number
- KR20050016706A KR20050016706A KR10-2004-7021677A KR20047021677A KR20050016706A KR 20050016706 A KR20050016706 A KR 20050016706A KR 20047021677 A KR20047021677 A KR 20047021677A KR 20050016706 A KR20050016706 A KR 20050016706A
- Authority
- KR
- South Korea
- Prior art keywords
- autoclaving
- cyclsonide
- aqueous suspension
- suspension
- sterile aqueous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
제조 | 회수율(%) |
실시예 1 | 100.1 |
비교 실시예 1 | 26.3 |
비교 실시예 2 | 78.1 |
Claims (7)
- 고압증기멸균 후의 사이클레소나이드 농도가 고압증기멸균 전의 것과 비교하여 95% 이상인, 고압증기멸균에 의해 멸균된 사이클레소나이드 함유 멸균 수성 현탁액.
- 제1항에 있어서, 히드록시프로필메틸셀룰로즈를 더 함유하는 사이클레소나이드 함유 멸균 수성 현탁액.
- 제2항에 있어서, 히드록시프로필메틸셀룰로즈가 히드록시프로필메틸셀룰로즈 2910인 사이클레소나이드 함유 멸균 수성 현탁액.
- 사이클레소나이드 함유 수성 현탁액을 고압증기멸균함으로써 멸균시키는 단계를 포함하는 사이클레소나이드 함유 멸균 수성 현탁액의 제조 방법.
- 제4항에 있어서, 고압증기멸균 후의 사이클레소나이드 농도가 고압증기멸균 전의 것과 비교하여 95% 이상인, 사이클레소나이드 함유 멸균 수성 현탁액의 제조 방법.
- 제4항 또는 제5항에 있어서, 사이클레소나이드 함유 수성 현탁액은 히드록시프로필메틸셀룰로즈를 더 함유하는 것인 사이클레소나이드 함유 멸균 수성 현탁액의 제조 방법.
- 제6항에 있어서, 히드록시프로필메틸셀룰로즈가 히드록시프로필메틸셀룰로즈 2910인 사이클레소나이드 함유 멸균 수성 현탁액의 제조 방법.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2002-00193399 | 2002-07-02 | ||
JP2002193399 | 2002-07-02 | ||
PCT/JP2003/008410 WO2004004739A1 (en) | 2002-07-02 | 2003-07-02 | Ciclesonide-containing sterile aqueous suspension |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050016706A true KR20050016706A (ko) | 2005-02-21 |
KR101020687B1 KR101020687B1 (ko) | 2011-03-11 |
Family
ID=30112281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020047021677A KR101020687B1 (ko) | 2002-07-02 | 2003-07-02 | 사이클레소나이드 함유 멸균 수성 현탁액 |
Country Status (18)
Country | Link |
---|---|
US (2) | US8182824B2 (ko) |
EP (2) | EP3513813A1 (ko) |
JP (1) | JP4559221B2 (ko) |
KR (1) | KR101020687B1 (ko) |
CN (1) | CN100366256C (ko) |
AU (1) | AU2003245043B2 (ko) |
BR (1) | BRPI0312377A8 (ko) |
CA (1) | CA2491724C (ko) |
EA (1) | EA009843B1 (ko) |
HK (1) | HK1080365B (ko) |
HR (1) | HRP20050062B1 (ko) |
IL (1) | IL165666A (ko) |
MX (1) | MXPA04012756A (ko) |
NO (1) | NO335022B1 (ko) |
NZ (1) | NZ537945A (ko) |
PL (1) | PL224989B1 (ko) |
RS (1) | RS57455B1 (ko) |
WO (1) | WO2004004739A1 (ko) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4364486B2 (ja) * | 2002-07-02 | 2009-11-18 | 帝人株式会社 | 無菌水性懸濁製剤 |
WO2004052374A1 (en) * | 2002-12-12 | 2004-06-24 | Altana Pharma Ag | Combination medicament |
WO2005025578A1 (en) * | 2003-09-16 | 2005-03-24 | Altana Pharma Ag | Use of ciclesonide for the treatment of respiratory diseases |
PE20050941A1 (es) * | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
WO2005102354A1 (en) * | 2004-04-20 | 2005-11-03 | Altana Pharma Ag | Use of ciclesonide for the treatment of respiratory diseases in a smoking patient |
GB0410995D0 (en) | 2004-05-17 | 2004-06-23 | Norton Healthcare Ltd | Heat sterilization of glucocorticosteroids |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US8679545B2 (en) * | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
JP5661985B2 (ja) | 2006-12-27 | 2015-01-28 | 帝人ファーマ株式会社 | 無菌性水性懸濁製剤 |
WO2011135585A2 (en) * | 2010-04-28 | 2011-11-03 | Cadila Healthcare Limited | Aqueous pharmaceutical solution of ciclesonide |
WO2022231532A1 (en) * | 2021-04-29 | 2022-11-03 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Process for the preparation of sterilized suspensions for the inhalation by nebulization |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3288679A (en) * | 1966-03-23 | 1966-11-29 | Squibb & Sons Inc | Steroidal compositions and method of use |
US3692430A (en) * | 1971-06-18 | 1972-09-19 | John W Timmons | Liquid pumping system |
US3962430A (en) | 1974-08-07 | 1976-06-08 | Merck & Co., Inc. | Sterilization of solid non-electrolyte medicinal agents employing sodium chloride |
SE8600632D0 (sv) * | 1986-02-13 | 1986-02-13 | Kabivitrum Ab | Novel pharmaceutical composition |
SE9704186D0 (sv) * | 1997-11-14 | 1997-11-14 | Astra Ab | New composition of matter |
US6066292A (en) * | 1997-12-19 | 2000-05-23 | Bayer Corporation | Sterilization process for pharmaceutical suspensions |
JP2001048807A (ja) * | 1999-08-04 | 2001-02-20 | Wakamoto Pharmaceut Co Ltd | 難溶性薬物を水に溶解してなる製剤 |
AR026072A1 (es) * | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa |
AR026073A1 (es) * | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica acuosa que contiene ciclesonida |
EP1142565A4 (en) * | 1999-10-20 | 2004-03-17 | Teijin Ltd | AQUEOUS THERAPEUTIC COMPOSITIONS |
CA2429574C (en) | 2000-11-24 | 2009-02-10 | Breath Limited | Sterilisation of pharmaceuticals |
JP4364486B2 (ja) | 2002-07-02 | 2009-11-18 | 帝人株式会社 | 無菌水性懸濁製剤 |
US20040023935A1 (en) * | 2002-08-02 | 2004-02-05 | Dey, L.P. | Inhalation compositions, methods of use thereof, and process for preparation of same |
US20060293293A1 (en) * | 2003-05-22 | 2006-12-28 | Altana Pharma Ag | Salmeterol and ciclesonide combination |
-
2003
- 2003-07-02 EP EP19157419.3A patent/EP3513813A1/en not_active Withdrawn
- 2003-07-02 AU AU2003245043A patent/AU2003245043B2/en not_active Expired
- 2003-07-02 CN CNB038156105A patent/CN100366256C/zh not_active Expired - Lifetime
- 2003-07-02 KR KR1020047021677A patent/KR101020687B1/ko active IP Right Grant
- 2003-07-02 NZ NZ537945A patent/NZ537945A/en not_active IP Right Cessation
- 2003-07-02 EA EA200500123A patent/EA009843B1/ru not_active IP Right Cessation
- 2003-07-02 BR BRPI0312377A patent/BRPI0312377A8/pt not_active Application Discontinuation
- 2003-07-02 PL PL372940A patent/PL224989B1/pl unknown
- 2003-07-02 CA CA2491724A patent/CA2491724C/en not_active Expired - Fee Related
- 2003-07-02 JP JP2004519234A patent/JP4559221B2/ja not_active Expired - Lifetime
- 2003-07-02 US US10/519,484 patent/US8182824B2/en not_active Expired - Fee Related
- 2003-07-02 RS YU113404A patent/RS57455B1/sr unknown
- 2003-07-02 EP EP03738637A patent/EP1519734A4/en not_active Ceased
- 2003-07-02 WO PCT/JP2003/008410 patent/WO2004004739A1/en active Application Filing
- 2003-07-02 MX MXPA04012756A patent/MXPA04012756A/es active IP Right Grant
-
2004
- 2004-12-09 IL IL165666A patent/IL165666A/en active IP Right Grant
-
2005
- 2005-01-20 HR HRP20050062AA patent/HRP20050062B1/hr not_active IP Right Cessation
- 2005-02-01 NO NO20050529A patent/NO335022B1/no not_active IP Right Cessation
-
2006
- 2006-01-05 HK HK06100215.3A patent/HK1080365B/zh not_active IP Right Cessation
-
2009
- 2009-08-19 US US12/461,647 patent/US8268240B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8268240B2 (en) | Ciclesonide-containing sterile aqueous suspension | |
US7524834B2 (en) | Sterile powders, formulations, and methods for producing the same | |
JP5778384B2 (ja) | エスモロール処方物 | |
KR101086095B1 (ko) | 분무용 시클레소니드의 수성 현탁액 | |
JP2002510652A (ja) | 共溶媒処方物 | |
EP1368019B1 (en) | Esmolol formulation | |
JP4364486B2 (ja) | 無菌水性懸濁製剤 | |
CN114007588A (zh) | 比拉斯汀的稳定和保存的药物组合物 | |
JP2021521240A (ja) | ブリンゾラミドの眼科用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20140205 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20150130 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20160127 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20170201 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20180201 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20190129 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20200129 Year of fee payment: 10 |